Unknown

Dataset Information

<sup>68</sup>Ga-FAPI-46 PET/CT in the evaluation of gliomas: comparison with <sup>18</sup>F-FDG PET/CT and contrast-enhanced MRI.


ABSTRACT: Rationale: This study compared 68Ga-FAPI-46 PET/CT, 18F-fluorodeoxyglucose (FDG) PET/CT, and contrast-enhanced MRI (CE-MRI) for glioma imaging, classification, and recurrence detection and explored PET parameters and molecular pathological profiles. Methods: Between June 2020 and June 2024, we prospectively enrolled patients with space-occupying lesions in the brain or previously treated gliomas. All patients underwent sequential CE-MRI, 68Ga-FAPI-46, and 18F-FDG PET/CT. Diagnostic accuracy was assessed based on a reference standard, and PET parameters were analysed for correlations with WHO grading and molecular characteristics. Results: Forty-eight patients (median age, 51 years; 32 men) with 40 confirm

SUBMITTER: Ruan D 

PROVIDER: S-EPMC11610146 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature